Camel study questions PSA as a simple maturity marker
Bottom line
A new paper in Animals examines how prostate-specific antigen, or PSA, and testosterone change during sexual maturation in intact male dromedary camels, and finds that the two markers don’t move in parallel. In a cohort of 50 males split across five age groups, testosterone tracked age strongly, while PSA showed only a modest association, with the authors arguing that PSA dynamics may not be tightly androgen-dependent during maturation in this species. That matters because PSA is often interpreted through a human clinical lens, where androgen signaling is central, but camel reproductive physiology is shaped by age, puberty, and marked seasonality. (pmc.ncbi.nlm.nih.gov)
Why it matters: For veterinary professionals working with camelids, the study is a reminder that biomarker interpretation needs species-specific context. Prior camel research has shown testosterone rises with puberty and varies with breeding season, social status, and management conditions, so a prostate-associated marker that doesn’t closely mirror testosterone could complicate reproductive assessments if clinicians assume a simple endocrine relationship. In practice, that suggests PSA, if used at all in camel reproductive workups, should likely be interpreted alongside age, season, behavior, testicular findings, and semen or fertility data rather than as a standalone proxy for androgen status. (pmc.ncbi.nlm.nih.gov)
What to watch: The next question is whether follow-up studies validate PSA reference ranges in camels and show whether the marker has practical value for diagnosing prostate or fertility disorders in field settings. (mdpi.com)
Key facts
- Study type
- New paper in Animals
- Species
- Intact male dromedary camels
- Sample size
- 50 males
- Study design
- Five age groups
- Main finding
- PSA and testosterone did not move in parallel during sexual maturation
- Testosterone result
- Strong age correlation, r = 0.89
- PSA result
- Modest age association, r = 0.41
- Interpretation
- PSA may not be tightly androgen-dependent during maturation in this species
A newly published study in Animals reports that PSA and testosterone follow different trajectories during sexual maturation in male dromedary camels, suggesting that PSA may reflect prostate biology in ways that are not simply driven by androgen levels. Based on 50 intact males divided into five age groups, the authors found a strong age correlation for testosterone and a much weaker one for PSA, framing the result as evidence for potentially androgen-independent PSA dynamics during maturation. (pmc.ncbi.nlm.nih.gov)
That finding lands in a reproductive physiology landscape where testosterone in dromedary camels is already known to vary substantially with age, pubertal stage, and season. Earlier work found testosterone remains low in prepubertal animals, rises in peripubertal and mature camels, and peaks around the age of sexual maturity. Other studies have shown that male dromedaries are seasonal breeders, with reproductive activity and testosterone increasing during the rut, and that management factors such as social hierarchy and housing can also influence hormone levels and breeding behavior. (pubmed.ncbi.nlm.nih.gov)
Against that backdrop, the new paper’s main contribution is less about confirming testosterone biology than about questioning whether PSA should be read as a straightforward androgen-linked marker in camels. The abstract indicates testosterone had a substantial correlation with age, at r = 0.89, while PSA showed only a modest association, at r = 0.41. The implication is that prostate biomarker behavior during maturation may be partly uncoupled from circulating testosterone, at least in this species and life stage. That’s a notable departure from assumptions imported from human medicine, where PSA is deeply embedded in prostate disease monitoring, even though cross-species translation is often imperfect. (pmc.ncbi.nlm.nih.gov)
There doesn’t appear to be broad outside commentary yet on this specific camel study, which is not unusual for a niche clinical-research paper. But the broader camelid literature supports caution in overinterpreting any single reproductive biomarker. A recent review on reproductive disorders in male camelids emphasizes that libido, semen quality, and fertility can be shaped by season, overuse, disease, and exogenous hormone exposure, while other camel studies tie testosterone shifts to environmental cues and breeding status. In other words, endocrine markers are informative, but they sit inside a more complex reproductive picture. (mdpi.com)
Why it matters: For veterinarians, especially those involved in breeding soundness, theriogenology, or camelid practice, this study is a useful warning against assuming that a prostate-associated marker validated in one species will behave the same way in another. If PSA in camels is only loosely linked to age-related testosterone changes, then using it as a surrogate for puberty, androgen status, or reproductive readiness could be misleading without species-specific reference intervals and clinical validation. That’s especially relevant in dromedaries, where reproduction is already influenced by rutting season, nutrition, social dynamics, and management systems. (pubmed.ncbi.nlm.nih.gov)
The study also raises a practical research question: what is PSA actually measuring in the camel prostate during maturation? It may still prove clinically useful, but perhaps as a marker of tissue development or glandular activity rather than a direct readout of androgenic stimulation. Until there are stronger validation data linking PSA to pathology, fertility outcomes, imaging findings, or histology, clinicians should be careful about assigning too much diagnostic weight to the number alone. That’s an inference from the available evidence, rather than a conclusion the current literature has fully settled. (pmc.ncbi.nlm.nih.gov)
What to watch: The next step is validation work: larger cohorts, seasonal sampling, and studies that compare PSA with semen quality, ultrasonography, fertility outcomes, and confirmed reproductive tract disease. If those data emerge, PSA could either become a more useful adjunct marker in camel practice, or be relegated to a limited research role. For now, the paper is best read as an early signal that camel prostate biomarker dynamics may not map neatly onto familiar small-animal or human frameworks. (sciencedirect.com)